NO20034026D0 - Nytt preparat - Google Patents

Nytt preparat

Info

Publication number
NO20034026D0
NO20034026D0 NO20034026A NO20034026A NO20034026D0 NO 20034026 D0 NO20034026 D0 NO 20034026D0 NO 20034026 A NO20034026 A NO 20034026A NO 20034026 A NO20034026 A NO 20034026A NO 20034026 D0 NO20034026 D0 NO 20034026D0
Authority
NO
Norway
Prior art keywords
new preparation
preparation
new
Prior art date
Application number
NO20034026A
Other languages
English (en)
Other versions
NO20034026L (no
Inventor
Britta Siekmann
Barbro Thoring
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20034026D0 publication Critical patent/NO20034026D0/no
Publication of NO20034026L publication Critical patent/NO20034026L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20034026A 2001-03-15 2003-09-11 Nytt preparat NO20034026L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0100901A SE0100901D0 (sv) 2001-03-15 2001-03-15 New composition
PCT/SE2002/000476 WO2002074282A1 (en) 2001-03-15 2002-03-13 New composition

Publications (2)

Publication Number Publication Date
NO20034026D0 true NO20034026D0 (no) 2003-09-11
NO20034026L NO20034026L (no) 2003-11-11

Family

ID=20283373

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034026A NO20034026L (no) 2001-03-15 2003-09-11 Nytt preparat

Country Status (13)

Country Link
US (1) US20040096494A1 (no)
EP (1) EP1370239A1 (no)
JP (1) JP2004523577A (no)
KR (1) KR20030082971A (no)
CN (1) CN1496253A (no)
BR (1) BR0207760A (no)
CA (1) CA2435825A1 (no)
IL (1) IL156818A0 (no)
MX (1) MXPA03007093A (no)
NO (1) NO20034026L (no)
SE (1) SE0100901D0 (no)
WO (1) WO2002074282A1 (no)
ZA (1) ZA200306282B (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
CA2461349C (en) 2001-09-26 2011-11-29 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
GB0207529D0 (en) * 2002-04-02 2002-05-08 Norbrook Lab Ltd Injectable veterinary composition for small animals
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US7163958B2 (en) 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
ES2660172T3 (es) * 2004-05-19 2018-03-21 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Composición inyectable que comprende desoxicolato de sodio
EP1886667A1 (en) * 2006-08-08 2008-02-13 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Microemulsified drug formulation
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
MX363465B (es) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Tratamiento de la grasa submental.
CA2830298C (en) 2011-03-17 2016-08-16 Transdermal Biotechnology, Inc. Topical nitric oxide systems comprising lecithin and methods of use thereof
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871255B2 (en) * 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871257B2 (en) * 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871256B2 (en) * 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295637B2 (en) * 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9393264B2 (en) * 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9849160B2 (en) * 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314422B2 (en) * 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9320758B2 (en) * 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9724419B2 (en) * 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314417B2 (en) * 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US20140271938A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9750787B2 (en) * 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9241899B2 (en) * 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US20140271731A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
PL3585182T3 (pl) * 2017-02-21 2021-11-22 Dsm Ip Assets B.V. Wykorzystanie kompozycji paszowych do redukcji emisji metanu u przeżuwaczy i/lub poprawy wydajności przeżuwaczy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
SE9704833D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New formulation

Also Published As

Publication number Publication date
CN1496253A (zh) 2004-05-12
SE0100901D0 (sv) 2001-03-15
NO20034026L (no) 2003-11-11
KR20030082971A (ko) 2003-10-23
BR0207760A (pt) 2004-06-01
US20040096494A1 (en) 2004-05-20
MXPA03007093A (es) 2003-11-18
CA2435825A1 (en) 2002-09-26
ZA200306282B (en) 2004-11-23
IL156818A0 (en) 2004-02-08
JP2004523577A (ja) 2004-08-05
EP1370239A1 (en) 2003-12-17
WO2002074282A1 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
NO20034026L (no) Nytt preparat
NO20035208D0 (no) Nytt vaksine preparat
NO20033143D0 (no) Farmasoytisk preparat
IS7016A (is) Ný 4-anilínókínólín-3-karboxamíð
NO20030418L (no) Nytt farmasöytisk preparat
DE60227853D1 (de) Substituierte Pyridinylamine
NO20034774L (no) Melanokortinreseptorligander
NO20052239D0 (no) Fast preparat
DE50206892D1 (de) Substituierte imidazotriazinone
NO20034695L (no) Nytt preparat
NO20025805L (no) Farmasöytisk preparat
DK1373228T3 (da) Substituerede fluoralkoxyphenylsulfonylurinstoffer
NO20060375L (no) Famasoytisk preparat
NO20033829D0 (no) Antiviralt preparat
DE50213651D1 (de) Substituierte 4-aminocyclohexanole
NO20023392L (no) Preparat
ATA18372001A (de) Gelenksbolzenbaueinheit
ATA13992002A (de) Schlackengranulierungsanlage
DE60216967D1 (de) Substituierte cyclohexanderivate
AT500276B1 (de) Radschwenksystem
SE0004779D0 (sv) Preparat
ATA6162001A (de) Schneekette
SE0100199D0 (sv) New formulation
NO20015559D0 (no) Kreklinggel±
SE0102054D0 (sv) New Combination

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application